Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Proposes Expanding User Fees To Cosmetics Among New Areas

This article was originally published in The Tan Sheet

Executive Summary

The White House requests a 17% increase in FDA’s overall budget to $4.5 billion, including $855 million in direct appropriations for CFSAN, about $10 million less than its fiscal 2012 appropriation, and $473 million for CDER, about $5 million less than its current appropriation.

You may also be interested in...



FTC Continues Acai Crackdown With Blitz Against Affiliate Marketers

The Federal Trade Commission makes good on its promise to continue enforcement action against acai weight-loss products with 10 cases against affiliate marketers of the berry supplements.

President's Budget Proposal Points To Expanding FDA User Fees

President Obama's fiscal 2012 budget request concurs with FDA in recommending that Congress expand the type of user fees that industry pays for food safety enforcement reform.

NBTY Agrees To $2.1M Settlement With FTC For False DHA Claims

The Federal Trade Commission's ongoing crackdown on "bogus" health claims leads to a $2.1 million settlement with NBTY and two subsidiaries to resolve charges they overstated the amount and benefit of DHA in children's multivitamins.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS105576

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel